November 23, 2010 --
San Diego -- Volcano Corporation (Nasdaq: VOLC), a
leading developer and manufacturer of precision intravascular
diagnosis and therapy
guidance tools designed to enhance the treatment of coronary
and peripheral vascular disease, said today that it will be participating
in the 22nd Annual Piper Jaffray Health Care Conference on Tuesday,
November 30.
The presentation by Scott Huennekens, president and
chief executive officer, will begin at 2:30 p.m., Eastern
Standard Time (11:30 a.m., Pacific Standard Time). |
